Mary J. Kuhn, Executive VP, Operations at Talecris Biotherapeutics Holdings Corp. (TLCR), sold 46,130 shares at $21.99 ($1.0M) on 2010-09-01, disclosed to the SEC on 2010-09-03.
Scheduled sale ($1.0M) by Executive VP, Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TLCR | SELL | 2010-11-02 | $1.1M | — | Filing → |
| TLCR | SELL | 2010-10-04 | $1.1M | — | Filing → |
| TLCR | SELL | 2010-09-16 | $759K | — | Filing → |